The information provided by JY BioMed on this website, including the Investors section, is intended for general informational purposes only. It does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, nor does it constitute investment advice, legal advice, or a recommendation regarding any securities transaction. The materials may contain forward-looking statements relating to future operations, strategies, financial performance, or product development. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results may differ materially due to factors such as scientific, regulatory, manufacturing, operational, and market risks.

​

Investments in early-stage biotechnology companies involve substantial risks, including but not limited to, clinical trial uncertainties, regulatory approvals, intellectual property challenges, competition, and funding requirements. Past performance is not indicative of future results. JY BioMed assumes no obligation to update any forward-looking statements or publicly revise any information to reflect future events or developments, except as required by applicable laws. By accessing or using the information provided, you acknowledge and agree to the terms of this Legal Disclaimer and Risk Notice.

​

Summary of Key Risk Factors

• Clinical development risks and regulatory uncertainties

• Manufacturing scalability and supply chain risks

• Market competition and evolving scientific landscapes

• Dependence on key partnerships and funding availability

• Economic, geopolitical, and pandemic-related factors